Press release
GENEXI plans to allocate up to $42 million to support biotech startups
In mid-2017, GENEXI announced the official launch of a sustainable innovation ecosystem based on blockchain technology. The release of the blockchain-platform was a key step in the "road map" of GENEXI.
To date, the GENEXI ecosystem is a niche platform designed to draw the attention of the professional community and government to innovations in the field of pharmacology and biotechnology, and promote the implementation of blockchain technologies into modern medicine.
The mission of GENEXI is truly enormous - it is improving the quality and increasing the longevity around the world. Its effectuation is based on the achievement of such goals as assistance in attracting financial support to innovative startups, encouraging producers to create technologies to improve the efficiency and safety of products, integrating innovative pharmacology and biotechnology into the world market.
In early 2017, the doctor of medical sciences and the founder of the innovative company "BIOS" Sergey Tyurin presented the first project within GENEXI: the technology of decomposition of bacteriorhodopsin, molecules of which are used in medicine, cosmetology, agriculture and IT. Based on bacteriorhodopsin, a skin regeneration system was created. RESTET is a biomolecular cosmetic product, one of the most effective in the fight against psoriasis, atopic dermatitis, neurodermatitis and acne. "We were bribed by the fact that the drug has already been researched and it took a small amount of investment to run it. The technologies used have no analogues in the world and are protected by patents. Feedback was positive: we were convinced that the product works and does not cause side effects, "commented GENEXI CEO Aleksei Zheliaskov.
GENEXI issued a grant of $ 1 million to the project and outlined the main vector of its activity - selection of advanced products in the field of biotech and rewarding scientists who have been working on the future technologies for years. As reported by the leadership of GENEXI, a number of drugs for the treatment of Alzheimer's disease and oncological diseases are in the queue for consideration.
The technology of blockchain will allow GENEXI to deal a significant blow to such a market as the trade in counterfeit medical products. The particular importance of the new platform will be given to the fight against falsified and substandard drugs.
The platform's founder and serial entrepreneur Aleksei Zheliaskov united the best professionals in medicine, pharmacology, Internet technologies and agriculture in order to create a strong scientific personnel. He will also lead the council to assess the prospects for practical application and cost-effectiveness of startups. Carefully selected projects will be awarded with grants, which will be allocated from $ 12 to $ 42 million dollars.
In order to ensure that grants are justified and fair, GENEXI has partnered with leading research laboratories, institutes and medical consultants, including the leading Russian chemist Dr. Sergei Tyurin, American microbiologist Phyllis Martin, biotech analyst and geneticist Alexander Novoselov, Russian Research Institute of Toxicology and Hygiene, American Research Center for Agriculture.
By July 31 inclusive, anyone wishing to support biotech projects can join the platform. Maybe you are the one to influence the market and provide the humanity with cheaper medicines, more advanced crops and robot prosthesis available to every patient.
Genexi accelerates the transition of cutting-edge biotech projects from research to the market.
Genexi uses blockchain technologies to publish funding and grant information in real time, Promote and support Genexi Ecosystem, Bring decentralised protocols and digital tools into the biotech field, Empower researchers and entrepreneurs to implement their innovative ideas and Build a global community of biotech enthusiasts.
Anna Rafaelly - +74951209977
Presnenskaya emb., 12, Federation West Tower, Moscow, Russia -123100
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GENEXI plans to allocate up to $42 million to support biotech startups here
News-ID: 1093102 • Views: …
More Releases for Aleksei
CEC Chair: ODIHR did not rebuke Belarus election until final report
MINSK, 27 December (BelTA) – It was the first time the OSCE Office for Democratic Institutions and Human Rights voiced no discontent with Belarus election until their final report was released, said Chairperson of the Central Election Commission (CEC) of Belarus Lidia Yermoshina in an interview with the ONT TV Channel on 26 December, BelTA has learnt.
“There were no critical remarks until the morning of 20 December,” Lidia Yermoshina said.…
Belarusian opposition ‘bet heavily on street protests’
MINSK, 23 December (BelTA) – During the presidential election the Belarusian opposition was focused on street protests from the start, Ambassador Extraordinary and Plenipotentiary of Russia to Belarus Alexander Surikov told media on 23 December.
The diplomat said that it was obvious who will win the election from the start and the opposition bet heavily on street protests. Instead of fighting for votes they aimed to resolve problems via protests in…
Ten presidential candidates registered in Belarus
MINSK, 18 November (BelTA) – The Central Election Commission of Belarus has registered ten people as candidates for the Belarus presidency, BelTA has learned.
The candidates are incumbent president Alexander Lukashenko as well as Grigory Kostusev, Aleksei Mikhalevich, Vladimir Nekliaev, Yaroslav Romanchuk, Vitaly Rymashevsky, Andrei Sannikov, Nikolai Statkevich, Viktor Tereshchenko, and Dmitry Uss.
The Central Election Commission has denied registration to Vladimir Provalsky because only 118 signatures he had submitted turned out…
Ten people line up for race for Belarus presidency
MINSK, 9 November (BelTA) – Ten people have real chances of becoming the president of Belarus, Secretary of the Central Election Commission (CEC) of Belarus Nikolai Lozovik told BelTA.
Following preliminary examination of the authenticity of signatures given in support for nominating the presidential candidates, ten aspirants, who have provided over 100,000 signatures, except for Vladimir Provalsky, retain the right to continue the election campaign and the possibility of becoming presidential…
EU: freer election campaign in Belarus this year
The European Union praises a freer presidential election campaign in Belarus in 2010. This statement was made by Bundestag member, Chief of Staff of the German Chancellery and Federal Minister for Special Affairs Ronald Pofalla in Minsk on 4 November, BelTA has learnt.
“We see that the situation has improved in Belarus. The restrictions that existed before, in particular on collecting signatures for potential candidates, have been lifted,” he said.
Ronald…
OSCE to deploy long-term observation mission in Belarus in November
MINSK, 19 October (BelTA) – The OSCE mission will deploy its long-term observation mission in Belarus in November, BelTA learnt from Secretary of the Central Election Commission Nikolai Lozovik.
“The OSCE informed Belarus that it plans to send 40 long-term observers to the country in mid November,” Nikolai Lozovik stated. He added that the OSCE is set to send nearly 400 international observers to Belarus on the election day, December 19.
The…
